Additive Effect of Local Post-Procedural Cryoprevention on the Prevention of Post-ERCP Pancreatitis in Patients Receiving Rectal Diclofenac: A Multicenter Retrospective Study

Additive Effect of Local Post-Procedural Cryoprevention on the Prevention of Post-ERCP Pancreatitis in Patients Receiving Rectal Diclofenac: A Multicenter Retrospective Study - Additive Effect of Local Post-Procedural Cryoprevention on the Prevention of Post-ERCP Pancreatitis in Patients Receiving Rectal Diclofenac: A Multicenter Retrospective Study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059328

Enrollment

1200

Registered

2025-10-08

Start date

2025-10-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreaticobiliary disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent ERCP

Exclusion criteria

Exclusion criteria: 1. Patients under 20 years of age 2. Patients without a naive papilla 3. Patients who received any prophylactic measure for PEP other than rectal diclofenac (25 mg) 4. Patients with acute pancreatitis 5. Patients with surgically altered gastrointestinal anatomy, excluding those with Billroth I reconstruction 6. Patients who withdrew consent through the opt-out process

Design outcomes

Primary

Measure	Time frame
incidence of PEP	—

Countries

Japan

Contacts

Public ContactMasafumi Watanabe

Kitasato University School of Medicine Department of Gastroenterology

kokuwaki@kitasato-u.ac.jp+81-42-778-8111

Outcome results